Inquire About a Product| Product: | Clozapine-d8 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Catalog Number: | D4481 | ||||||||
| CAS Number: | 1185053-50-2 | ||||||||
| Synonyms: |
8-Chloro-11-(4-methyl-1-piperazinyl-d8)-5H-dibenzo[b,e][1,4]diazepine; HF-1854-d8; Liponex-d8 |
||||||||
| Pricing: |
|
||||||||
| Formula: | C18H11D8ClN4 | ||||||||
| Enrichment: | 98%D | ||||||||
| Molecular Weight: | 334.87 | ||||||||
| Structure: |
|
||||||||
| Category: | Neurochemical Compounds | ||||||||
| Literature References: |
Kane J, Honigfeld G, Singer J, Meltzer H., Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Archives of General Psychiatry, 1988, Sep, 45 (9): 789–796.; Hartling L, Abou-Setta AM, Dursun S, Mousavi SS, Pasichnyk D, Newton AS, Antipsychotics in adults with schizophrenia: comparative effectiveness of first-generation versus second-generation medications: a systematic review and meta-analysis. Annals of Internal Medicine, 2012, Oct, 157 (7): 498–511. |
||||||||
| MSDS: | |||||||||
| Applications: | A labeled atypical antipsychotic medication. Used to treat schizophrenia and sometimes bipolar disorder and borderline personality disorder. Causes agranulocytosis. Used only in patients that have not responded to any other anti-psychotic treatments. |